Dihydroboldos 100 mg/mL (Dihydroboldenone Cypionate)
Dihydroboldenone cypionate
Active ingredient: Dihydroboldenone cypionate
Category: An anabolic steroid derived from dihydrotestosterone (DHT)
Dosage form: Injectable formulation
Carrier oil: Blend of MCT oil and grapeseed oil
- Spedizione (se il prodotto è in stock): 3 giorni lavorativi di processing e dai 5 ai 20 giorni lavorativi di spedizione
- Spese di Processing e spedizione: 27€ in tutta Italia
Profile of Dihydroboldenone Cypionate (1-Testosterone)
The dihydroboldenone cypionate, known as 1-Testosterone, is an anabolic steroid belonging to the family of dihydrotestosterone (DHT) derivatives. It acts as the 5-alpha-reduced form of boldenone (Equipoise) and shares structural traits with methenolone (Primobolan).
The main structural difference lies in the absence of the 1-methyl group, which appears in Primobolan to improve oral bioavailability.
Dihydroboldenone cypionate counts as a potent non-estrogenic anabolic. Lab trials point to an anabolic activity rated at twice as much as testosterone propionate, alongside an equivalent androgenicity level. This yields an estimated anabolic-to-androgenic ratio hovering around 2:1, marking it as a powerful compound.
Bodybuilders value dihydroboldenone cypionate for its capacity to drive solid, lean muscle gains, avoiding heavy water retention or estrogenic side effects.
Chemical Structure and Biological Characteristics
Dihydroboldenone cypionate is a direct derivative of DHT carrying an extra double bond between carbons 1 and 2 (1-ene). This specific structural modification helps to:
-
stabilize the 3-keto group
-
increase anabolic effectiveness
-
reduce estrogen conversion
Due to these traits, researchers classify the compound as non-estrogenic. Gynecomastia, water retention, and estrogen-mediated fat accumulation do not usually appear during use.
Muscle Gain Characteristics
The results delivered by dihydroboldenone cypionate consist primarily of lean, dense muscle mass, driven by tissue growth rather than subcutaneous fluids.
Athletes turn to it during cutting phases when:
-
Muscle separation remains a priority
-
Water retention stays minimal
-
Rapid weight gain is not the goal
Thanks to the significant increase in strength, it can still be used in cycles of controlled mass
Cholesterol and Cardiovascular System Impact
Dihydroboldenone cypionate impacts the lipid profile more heavily than testosterone and nandrolone, largely because it does not aromatize.
Even so, its effects remain milder than those caused by many 17-alpha-alkylated steroids.
Like all anabolic steroids, it can:
-
lower HDL cholesterol
-
raise LDL cholesterol
-
alter blood pressure
-
promote left ventricular hypertrophy
Improper or prolonged use will raise cardiovascular risk.
Tolerability and Specific Usage Considerations
Dihydroboldenone cypionate is known to be intrinsically irritating. Reported local effects include:
-
discomfort or pain at the injection site
-
reddening of the tissues
-
skin irritation from transdermal variants
Some users note a burning sensation during urination, which is a rare and generally harmless side effect.
Compared to boldenone, dihydroboldenone cypionate puts less strain on the hematocrit while delivering greater strength gains. This matches the potency profile of Primobolan at a higher level.
Primary Effects
-
Lean muscle mass gains paired with potential body fat reduction
-
Anabolic activity reaching twice the potency of testosterone
-
Absence of gynecomastia and estrogenic effects
-
Lower androgenicity than testosterone
-
Noticeable increases in raw strength
-
Zero water retention
-
Suitability for mass-control and definition cycles
Potential Side Effects
-
Oily skin and acne breakouts
-
Irritation at the injection site
-
Increased body and facial hair growth
-
Hair loss in genetically predisposed individuals
-
Virilization risks for women, including clitoral enlargement
-
HDL reduction alongside LDL increases
-
Blood pressure spikes in rare cases
-
Mild liver toxicity risks
Pharmacological Profile
-
Half-life: 6–8 days
-
Injection frequency: every 5–7 days
Recommended Dosages
Dihydroboldenone cypionate has never been approved for human use; therefore, there are no official guidelines.
In non-therapeutic uses, the following are commonly reported:
-
Injectable form (cypionate): 100–400 mg weekly
-
Cycle length: 6–12 weeks
Pharmaceutical Form
Oily solution packaged for intramuscular injection.
Contraindications
-
Pregnancy
-
Confirmed or suspected prostate or breast tumors
-
Breastfeeding
-
Hypersensitivity to the active substance or excipients
-
Hypercalcemia
Storage Guidelines
-
Keep out of children’s reach
-
Store in a cool, dry place.
-
Protect from direct sunlight
-
Keep at room temperature
-
Discard past the expiration date
You must be logged in to post a review.

















Reviews
There are no reviews yet.